43 drug makers selected as innovative pharmaceutical firms

The Ministry of Health and Welfare announced Monday a list of 43 innovative pharmaceutical firms that post more than 100 billion won in sales and invest at least 5 percent of their revenue in research and development or those that record less than 100 billion won in sales but spend more than 7 percent on R&D.

The designated drug firms are: Kwangdong, Green Cross, Daewoong, Daewon, Dongkuk, ...